Clarithromycin: Clinical Trials

56 trials of Clarithromycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 7 unknown, 6 terminated, 4 active not recruiting. 56 Phase 2, 6 Phase 3, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 256Completed 31, Unknown 7, Terminated 6, Active not recruiting 4, Recruiting 4, Not yet recruiting 2, Withdrawn 2
Phase 36Completed 4, Recruiting 1, Unknown 1
Phase 15Completed 4, Recruiting 1

Follow Clarithromycin: new trials by email Literature Review of Clarithromycin trials Research Report on Clarithromycin

Trials (filtered) newest first · largest first

All 56 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin - Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection
Phase 2Not yet recruitingThe University of Queensland3002027-04-012026-03-20
Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection
Vonoparazan, Vitamin D, Probiotic - HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection
Phase 2RecruitingTanta University1322026-02-152026-09-09
Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC
SKB264, Clarithromycin - Ovarian Epithelial Cancer
Phase 2Active not recruitingSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.202026-01-162026-06-01
Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma
Esomeprazole, Bismuth tripotassium dicitrate, Tetracycline, and Metronidazole - MALT Lymphoma of Stomach
Phase 2Not yet recruitingNational Taiwan University Hospital402025-09-012025-08-27
Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
Oxaliplatin With S-1 (SOX) Combined H. Pylori Eradication (Amoxicillin + clarithromycin + omeprazole + colloidal bismuth subcitrate), Oxaliplatin With S-1 (SOX) - Chemotherapy Effect
Phase 2RecruitingSixth Affiliated Hospital, Sun Yat-sen University1982024-12-312026-08-06
Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori
Black Seed Oil Cap/Tab, Vonoprazan, Amoxicillin and Clarithromycin - Helicobacter Pylori Infection
Phase 2Active not recruitingAin Shams University902023-08-152026-09-14
Furazolidone Quadruple Regimen Eradicate H. Pylori Infection
Furazolidone, Clarithromycin - Helicobacter Pylori Infection, Eradication
Phase 1 / Phase 2CompletedLiaocheng People's Hospital4932022-08-012025-02-12
Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients
Selinexor, Clarithromycin, Pomalidomide - Myeloma Multiple, Myeloma
Phase 2TerminatedWeill Medical College of Cornell University42021-12-292023-10-25
Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy
Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks., Investigational [RCA4]: standard (RC) plus amoxicillin/clavulanate (A) for 4 weeks. - Buruli Ulcer
Phase 2UnknownFundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID)1402021-12-012024-05-16
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
Daratumumab SC, Clarithromycin, Pomalidomide - Multiple Myeloma, Refractory Multiple Myeloma
Phase 2Active not recruitingWeill Medical College of Cornell University112021-10-282026-05-20
Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children
Esomeprazole, Lansoprazole, Amoxicillin - Helicobacter Pylori Infection
Phase 2 / Phase 3CompletedFinni Kollins512021-08-012023-05-17
A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Bedaquiline, Clarithromycin, Ethambutol - Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Phase 2 / Phase 3CompletedJanssen Pharmaceutical K.K.1292021-01-082026-04-15
Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early
Clarithromycin - COVID-19, Virus Diseases
Phase 2CompletedHellenic Institute for the Study of Sepsis902020-05-062021-01-11
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Amikacin, Tigecycline, Imipenem - Pulmonary Disease Due to Mycobacteria (Diagnosis)
Phase 2 / Phase 3RecruitingThe University of Queensland3002020-03-022026-05-11
Clarithromycin Mechanisms in Hypersomnia Syndromes
Clarithromycin, Placebo - Narcolepsy Without Cataplexy, Idiopathic Hypersomnia
Phase 2CompletedEmory University832019-09-042026-08-07
Safety Trial of Herbal Melanin in Gastritis Patients
Herbal Melanin, Nexium, Amoxil - Acid Dyspepsia, Gastritis
Phase 2UnknownKing Abdullah International Medical Research Center1322018-03-012018-02-09
Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm
Clarithromycin (Not used as of 4/2020), Placebo (Not used as of 4/2020), Transdermal flumazenil (Added 4/2020) - Parkinson Disease
Phase 1 / Phase 2CompletedNicolaas Bohnen, MD, PhD342018-01-292023-01-10
Flufenamic Acid for Hospitalised Influenza Infection
FFA, clarithromycin, oseltamivir, Oseltamivir alone - Influenza A
Phase 2UnknownThe University of Hong Kong2002018-01-082019-10-22
Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma
clarithromycin and lenalidomide - Mucosa Associated Lymphoid Tissue (MALT) Lymphoma
Phase 2CompletedInternational Extranodal Lymphoma Study Group (IELSG)442017-04-032025-01-30
Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma
clarithromycin, Lenalidomide, Dexamethasone - Relapse/Refractory Multiple Myeloma
Phase 2WithdrawnSun Yat-sen University2016-12-012018-08-14

Showing 20 of 56. Sign in to see all of them.

Conditions studied

Multiple Myeloma (16)  ·  HIV Infections (5)  ·  Lymphoma, B-Cell, Marginal Zone (5)  ·  Mycobacterium avium-intracellulare Infection (5)  ·  Acquired Immunodeficiency Syndrome (4)  ·  Neoplasms, Plasma Cell (4)  ·  Lymphoma (3)  ·  Recurrence (3)  ·  AIDS-Related Opportunistic Infections (2)  ·  Aggressive Periodontitis (2)  ·  Gastritis (2)  ·  Helicobacter Infections (2)  ·  Idiopathic Hypersomnia (2)  ·  Infections (2)  ·  Mycobacterium Infections, Nontuberculous (2)

Sponsors

Weill Medical College of Cornell University (6)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (4)  ·  Fred Hutchinson Cancer Center (2)  ·  Henrik Gregersen (2)  ·  The University of Queensland (2)  ·  Universidade Estadual Paulista Júlio de Mesquita Filho (2)  ·  Ain Shams University (1)  ·  Anderson Clinical Research (1)  ·  Andres J. M. Ferreri (1)  ·  Emory University (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  Finni Kollins (1)  ·  Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID) (1)  ·  Hamamatsu University (1)  ·  Hellenic Institute for the Study of Sepsis (1)

Countries

United States (25)  ·  China (4)  ·  Taiwan (4)  ·  Denmark (3)  ·  South Korea (3)  ·  United Kingdom (3)  ·  Brazil (2)  ·  Egypt (2)  ·  Italy (2)  ·  Japan (2)  ·  Australia (1)  ·  Austria (1)  ·  Benin (1)  ·  Canada (1)  ·  Germany (1)

Top investigators

Ruben Niesvizky, MD (3)  ·  Henrik Gregersen, MD (2)  ·  Leona Holmberg (2)  ·  Adila SA Elobeid, PhD (1)  ·  Andrew Wilcock (1)  ·  Armando Sardi, M.D. (1)  ·  Benson CA (1)  ·  Bruce K Rubin, MEngr,MD,MBA (1)  ·  Chaisson R (1)  ·  Chaisson RE (1)  ·  Charles Arthur Peloquin (1)  ·  Chirgwin K (1)  ·  Currier JS (1)  ·  Drusano G (1)

Results publications

PMID 16437639, PMID 17466292, PMID 17608775, PMID 1771934, PMID 17989313, PMID 20616418, PMID 23299315, PMID 24576165, PMID 25935794, PMID 26094838, PMID 27185079, PMID 28191328, PMID 28497487, PMID 30123673, PMID 30203587, PMID 30230047, PMID 30352784, PMID 30792190, PMID 31111585, PMID 31257591, PMID 31916648, PMID 32350723, PMID 33197289, PMID 34031871, PMID 34363189, PMID 35804454, PMID 36546422, PMID 37393120, PMID 38573915, PMID 38826786, PMID 40948663, PMID 42104494

NIH funding

2014 (1), P30CA015083 (1), P30CA015704 (1), P30CA016672 (1), R01NS099535 (1), R01NS111280 (1)